News
News on changes to the healthcare professionals who can issue fit to work notes from 1 July 2022 in England, Scotland and Wales.
An app that links to Apple Watch technology has been granted FDA approval to help monitor some motor symptoms experienced by people with Parkinson’s.
On 9 June Peers debated the importance of access to neurological healthcare services in the House of Lords. At Parkinson’s UK, we encouraged members to highlight the importance of access to healthcare professionals for our community.
We’re calling on the Parkinson’s community to take part in 5 important clinical studies that are currently at risk of closure.
Parkinson’s UK is joining with The Neurological Alliance as part of their #BackThe1in6 campaign. We’re calling on the governments across the UK to prioritise services for the 1 in 6 people with a neurological condition and establish a Neuro Taskforce.
Biotech company, NRG Therapeutics, has today announced an Innovate UK award to continue its drug development project, supported by the Parkinson's Virtual Biotech, into life-changing new treatments.
Our chair, Gary Shaughnessy, shares updates from our recent meeting of trustees, from promising new research initiatives to a promise to abseil down a building in Northern Ireland.
Research led by Cambridge University and part funded by Parkinson’s UK shows that a form of brain scan could help identify those at risk of specific Parkinson’s symptoms.
Our reaction to prescription charges in England being frozen to help people with the cost of living.
This Dementia Action Week we're calling on the UK government to provide support to help people with Parkinson's-related dementia and their families.